Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 May;48(5):463–465. doi: 10.1136/jcp.48.5.463

Thyroid antoantibodies and the response to thyrotropin releasing hormone in patients with subclinical hypothyroidism.

O A Mojiminiyi 1, V Rege 1, J Bolodeoku 1, A H Wilcox 1, J L Barron 1
PMCID: PMC502625  PMID: 7629294

Abstract

AIM--To evaluate the clinical usefulness of the thyrotropin releasing hormone (TRH) test and estimation of thyroid autoantibody concentrations in patients with borderline raised thyroid stimulating hormone (TSH). METHODS--The records of 34 consecutive patients with persistent borderline increased TSH (4.4-9.9 mU/l) referred to the Medical Investigation Unit were reviewed. The response of patients with thyroid autoantibodies to the TRH test was compared with that of patients with a negative antibody screen. RESULTS--Eleven (44%) of 25 patients with positive anti-thyroid microsomal and/or thyroglobulin antibody tests and three (33%) of nine patients with a negative antibody screen had hypothyroid responses to TRH. Neither age nor sex affected the response to TRH. Basal TSH alone was poorly correlated with these indices. Twelve (35%) patients who had elevated basal TSH had a normal response to the TRH test. CONCLUSION--Patients with positive or negative thyroid autoantibodies and an exaggerated response to the TRH test should be regarded as hypothyroid and treated with thyroxine. Patients with positive thyroid autoantibodies and normal TSH response may subsequently develop hypothyroidism and should be given long term follow up.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastenie P. A., Vanhaelst L., Neve P. Coronary-artery disease in hypothyroidism. Lancet. 1967 Dec 9;2(7528):1221–1222. doi: 10.1016/s0140-6736(67)90562-4. [DOI] [PubMed] [Google Scholar]
  2. Brown C. A., Hennessey J. V. Clinical significance of mildly elevated thyrotropin levels with normal thyroxine levels. South Med J. 1989 Jun;82(6):681–685. doi: 10.1097/00007611-198906000-00003. [DOI] [PubMed] [Google Scholar]
  3. Caron P., Calazel C., Parra H. J., Hoff M., Louvet J. P. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf) 1990 Oct;33(4):519–523. doi: 10.1111/j.1365-2265.1990.tb03889.x. [DOI] [PubMed] [Google Scholar]
  4. Evered D. C., Ormston B. J., Smith P. A., Hall R., Bird T. Grades of hypothyroidism. Br Med J. 1973 Mar 17;1(5854):657–662. doi: 10.1136/bmj.1.5854.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Finucane P., Rudra T., Hsu R., Newcombe R., Pathy M. S., Scanlon M. F., Woodhead J. S. Thyrotropin response to thyrotropin-releasing hormone in elderly patients with and without acute illness. Age Ageing. 1991 Mar;20(2):85–89. doi: 10.1093/ageing/20.2.85. [DOI] [PubMed] [Google Scholar]
  6. Gordin A., Lamberg B. A. Natural course of symptomless autoimmune thyroiditis. Lancet. 1975 Dec 20;2(7947):1234–1238. doi: 10.1016/s0140-6736(75)92073-5. [DOI] [PubMed] [Google Scholar]
  7. Hamblin P. S., Dyer S. A., Mohr V. S., Le Grand B. A., Lim C. F., Tuxen D. V., Topliss D. J., Stockigt J. R. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab. 1986 Apr;62(4):717–722. doi: 10.1210/jcem-62-4-717. [DOI] [PubMed] [Google Scholar]
  8. Kabadi U. M. 'Subclinical hypothyroidism'. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med. 1993 Apr 26;153(8):957–961. doi: 10.1001/archinte.153.8.957. [DOI] [PubMed] [Google Scholar]
  9. Mariotti S., Barbesino G., Caturegli P., Bartalena L., Sansoni P., Fagnoni F., Monti D., Fagiolo U., Franceschi C., Pinchera A. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab. 1993 Nov;77(5):1130–1134. doi: 10.1210/jcem.77.5.8077303. [DOI] [PubMed] [Google Scholar]
  10. Rae P., Farrar J., Beckett G., Toft A. Assessment of thyroid status in elderly people. BMJ. 1993 Jul 17;307(6897):177–180. doi: 10.1136/bmj.307.6897.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Robuschi G., Safran M., Braverman L. E., Gnudi A., Roti E. Hypothyroidism in the elderly. Endocr Rev. 1987 May;8(2):142–153. doi: 10.1210/edrv-8-2-142. [DOI] [PubMed] [Google Scholar]
  12. Roti E., Gardini E., Minelli R., Bianconi L., Braverman L. E. Prevalence of anti-thyroid peroxidase antibodies in serum in the elderly: comparison with other tests for anti-thyroid antibodies. Clin Chem. 1992 Jan;38(1):88–92. [PubMed] [Google Scholar]
  13. Tibaldi J., Barzel U. S. Thyroxine supplementation. Method for the prevention of clinical hypothyroidism. Am J Med. 1985 Aug;79(2):241–244. doi: 10.1016/0002-9343(85)90015-4. [DOI] [PubMed] [Google Scholar]
  14. Tunbridge W. M., Brewis M., French J. M., Appleton D., Bird T., Clark F., Evered D. C., Evans J. G., Hall R., Smith P. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):258–262. doi: 10.1136/bmj.282.6260.258. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES